Search
Thursday 23 April 2015
  • :
  • :
Latest Update

Positive Stocks Investor’s Alert - SAP SE, (NYSE:SAP), FireEye, (NASDAQ:FEYE), Gannett Co., (NYSE:GCI), Regeneron Pharmaceuticals, (NASDAQ:REGN)

On Tuesday, Shares of SAP SE (NYSE:SAP), gained 2.52% to $74.14.

SAP SE, declared exceptionally strong growth in the cloud. First quarter non-IFRS cloud subscriptions and support revenue grew 131% year-over-year (95% at constant currencies). New cloud bookings, the key measure for SAP’s sales success in the cloud, raised 121% in the first quarter to €120 million.

The Company had a very strong cloud and software revenue performance with 24% growth in non-IFRS cloud and software revenue (12% at constant currencies) to €3.66 billion.

Non-IFRS operating profit raised 15% (decrease of 2% at constant currencies) to €1.06 billion.

SAP HANA continues to be a major growth driver for the Company. This quarter the number of HANA customers surpassed 6,400, almost doubling from just one year ago. SAP S/4HANA’s robust early traction – more than 370 SAP S/4HANA customers year-to-date – was a major catalyst in HANA’s broader market adoption across all industries and regions.

SAP HANA also continues to evolve as a development platform. The HANA Cloud Platform, our Platform as a Service offering, enables organizations to extend and customize SAP applications quickly and easily in the cloud. This new offering is building noteworthy momentum and has already attracted about 1,400 customers in a short period of time.

SAP SE provides application and analytics software and software-related services for enterprises worldwide. The company offers solutions covering various lines of businesses, counting asset administration, commerce, finance, human resources, manufacturing, marketing, sales, service, sourcing and procurement, supply chain, and sustainability, in addition to research and development, and engineering.

Shares of FireEye, Inc. (NASDAQ:FEYE), gained 2.49% to $43.49, during its last trading session.

HP (HPQ) and FireEye, Inc. (FEYE) declared a first of its kind, go-to-market partnership to make incident response, compromise assessment and threat detection offerings accessible to HP Enterprise Services’ most planned clients globally.

Customers will benefit from HP Enterprise Services’ unparalleled global reach, portfolio of world-class security service offerings, counting a comprehensive suite of security remediation services underpinned by FireEye’s advanced threat detection, intelligence, methodologies and incident response expertise. The companies will develop an industry standard reference architecture providing customers with a blueprint for advanced threat protection services and incident response capabilities.

Together, HP Enterprise Services and FireEye will jointly go to market with these offerings:

  • Global Incident Response from HP and Mandiant will investigate, assess and resolve cyber security events ranging from single-system compromises to enterprise-wide intrusions by advanced attack groups that span hundreds of thousands of systems.
  • Advanced Compromise Assessment from HP and Mandiant is a vital step in answering the most important question for every enterprise, whether or not they have been breached. This offering provides HP Enterprise Services planned customers with the most advanced compromise assessment in the industry and is the first step in transforming their IT security program.

FireEye, Inc., together with its auxiliaries, provides cybersecurity solutions for detecting, preventing, and resolving cyber-attacks. The company offers vector-specific appliance solutions that provide threat protection from network to endpoint for inbound and outbound network traffic that may contain sensitive information.

At the end of Tuesday’s trade, Shares of Gannett Co., Inc. (NYSE:GCI), gained 2.45% to $36.

Gannett Co., said that it has chosen TEGNA as the name for the new Broadcasting and Digital company. Gannett is in the process of creating two publicly traded companies: one exclusively focused on its Broadcasting and Digital businesses, and the other on its Publishing business and associated digital assets. TEGNA will trade on the New York Stock Exchange under the ticker symbol TGNA.

TEGNA’s trusted portfolio of television and digital businesses will provide the content that matters and brands that deliver. TEGNA’s broadcasting business will comprise 46 television stations and be the largest independent station group of major network associates in the top 25 markets. The TV stations will reach about one-third of all television households nationwide and represent the #1 NBC associate group, #1 CBS associate group and #4 ABC associate group (not taking into account owner-operators). Millions of consumers will rely on TEGNA’s broadcasting stations for news and information vital to their daily lives. Combined, TEGNA’s TV stations are renowned for their outstanding journalism and have been recognized with such honors as the Edward R. Murrow, Alfred I. duPont, George Foster Peabody, National Headliner, George Polk and Emmy awards.

Gannett Co., Inc. operates as a media and marketing solutions company. It operates through three segments: Broadcasting, Publishing, and Digital. The Broadcasting segment owns and operates 46 television stations that produce local programming, such as news, sports, and entertainment; and associated online sites.

Finally, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), ended its last trade with 2.39% gain, and closed at $463.22.

Regeneron Pharmaceuticals, declared that it will report its first quarter 2015 financial and operating results on Thursday, May 7, 2015, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.

To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International). A link to the webcast may be accessed from the ‘Events and Presentations’ page of Regeneron’s website at www.regeneron.com.

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *